LAMATTINA JOHN L
Insider CIK 1216074 · ZFGN Director · IMNM Director · LGND Director · HGSI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-10 | 2026-06-12 | 232 | $248.11 | $57.6K | 31,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-10 | 2026-06-12 | 697 | $249.53 | $173.9K | 30,374 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-10 | 2026-06-12 | 3,405 | $251.62 | $856.8K | 26,969 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-10 | 2026-06-12 | 257 | $247.22 | $63.5K | 31,303 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-06-05 | 2026-06-09 | 2,938 | — | $0 | 2,938 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-06-05 | 2026-06-09 | 836 | — | $0 | 31,560 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-06 | 2026-03-31 | 2,161 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-06 | 2026-03-31 | 2,161 | $200.76 | $433.8K | 30,724 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-06 | 2026-03-31 | 2,161 | $114.15 | $246.7K | 32,885 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-11-07 | 2025-11-12 | 2,034 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-11-07 | 2025-11-12 | 2,145 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-11-07 | 2025-11-12 | 2,034 | $69.51 | $141.4K | 32,758 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-07 | 2025-11-12 | 2,145 | $205.45 | $440.7K | 30,724 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-11-07 | 2025-11-12 | 2,145 | $66.13 | $141.8K | 32,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-11-07 | 2025-11-12 | 2,034 | $205.45 | $417.9K | 30,724 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-06-06 | 2025-06-10 | 5,783 | — | $0 | 5,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-06-06 | 2025-06-10 | 1,209 | — | $0 | 30,724 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-11-27 | 2024-12-02 | 2,406 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-11-27 | 2024-12-02 | 2,406 | $52.30 | $125.8K | 31,921 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-11-27 | 2024-12-02 | 2,406 | $123.65 | $297.5K | 29,515 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-06-14 | 2024-06-18 | 5,444 | — | $0 | 5,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-06-14 | 2024-06-18 | 1,252 | — | $0 | 29,515 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-06-09 | 2023-06-13 | 5,461 | — | $0 | 5,461 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-06-09 | 2023-06-13 | 1,142 | — | $0 | 28,263 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 6,500 | — | $0 | 6,500 | SEC↗ |
| IMNM Immunome Inc. | A Award | 2023-01-15 | 2023-01-17 | 15,125 | $4.00 | $60.5K | 66,953 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 4,484 | — | $0 | 4,484 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 6,500 | — | $0 | 6,500 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 26,402 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-11-16 | 2021-11-17 | 4,835 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-11-16 | 2021-11-17 | 4,835 | $161.86 | $782.6K | 25,398 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-11-16 | 2021-11-17 | 4,835 | $32.30 | $156.2K | 30,233 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 25,398 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2021-05-28 | 2021-06-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-05-24 | 2021-05-26 | 338 | $18.44 | $6.2K | 46,726 | SEC↗ |
| IMNM Immunome Inc. | P Buy | 2021-05-24 | 2021-05-26 | 5,102 | $18.58 | $94.8K | 51,828 | SEC↗ |
| IMNM Immunome Inc. | A Award deriv | 2020-11-03 | 2020-11-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 46,388 | — | $0 | 0 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 0 | SEC↗ |
| IMNM Immunome Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 11,111 | — | $0 | 11,111 | SEC↗ |
| IMNM Immunome Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 46,388 | — | $0 | 46,388 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 24,768 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-08-01 | 2019-08-05 | 2,500 | — | $0 | 4,835 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-08-01 | 2019-08-05 | 2,500 | $32.30 | $80.8K | 24,784 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-08-01 | 2019-08-05 | 847 | $95.58 | $81.0K | 23,937 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2019-06-26 | 2019-06-27 | 27,000 | — | $0 | 27,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-07 | 835 | — | $0 | 22,284 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award | 2019-01-24 | 2019-01-28 | 10,844 | $4.38 | $47.5K | 31,376 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 3,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-09-04 | 2018-09-05 | 3,335 | $254.96 | $850.3K | 21,449 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 3,335 | $12.53 | $41.8K | 24,784 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 21,449 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2018-06-06 | 2018-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-06-04 | 2018-06-04 | 4,000 | — | $0 | 3,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-06-04 | 2018-06-04 | 4,000 | $194.51 | $778.0K | 20,956 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-06-04 | 2018-06-04 | 4,000 | $12.53 | $50.1K | 24,956 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-03-05 | 2018-03-06 | 3,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-03-05 | 2018-03-06 | 3,335 | $10.12 | $33.8K | 24,291 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-03-05 | 2018-03-06 | 3,335 | $160.90 | $536.6K | 20,956 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award | 2018-01-03 | 2018-01-05 | 9,169 | $5.18 | $47.5K | 20,532 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-11-17 | 2017-11-17 | 4,000 | — | $0 | 3,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-17 | 2017-11-17 | 4,000 | $139.79 | $559.2K | 20,956 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-11-17 | 2017-11-17 | 4,000 | $10.12 | $40.5K | 24,956 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2017-06-21 | 2017-06-23 | 14,500 | — | $0 | 14,500 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-26 | 2,456 | $113.50 | $278.8K | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-26 | 666 | — | $0 | 20,956 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award | 2017-02-13 | 2017-02-14 | 11,363 | $4.18 | $47.5K | 11,363 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-06-30 | 2016-07-01 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | $119.30 | $277.8K | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 20,102 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 188 | — | $0 | 20,290 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-01-25 | 2016-01-27 | 9,150 | — | $0 | 9,150 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2015-11-12 | 2015-11-13 | 1,500 | — | $0 | 19,480 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2015-07-13 | 2015-07-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-27 | 2,754 | $89.75 | $247.2K | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 925 | — | $0 | 20,980 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2015-01-08 | 2015-01-12 | 1,593 | — | $0 | 9,554 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2014-11-24 | 2014-11-26 | 2,785 | — | $0 | 20,055 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-05 | 3,312 | $67.53 | $223.7K | 3,312 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 333 | — | $0 | 22,840 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 1,151 | — | $0 | 22,507 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-03-18 | 2014-03-20 | 5,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-03-18 | 2014-03-20 | 5,000 | $8.97 | $44.9K | 26,356 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-03-18 | 2014-03-20 | 5,000 | $78.83 | $394.1K | 21,356 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2013-11-20 | 2013-11-21 | 3,800 | — | $0 | 21,356 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 7,335 | $32.30 | $236.9K | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 2,925 | — | $0 | 24,460 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 696 | — | $0 | 25,156 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 3,991 | $14.25 | $56.9K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 25,000 | $14.25 | $356.3K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer | 2012-07-30 | 2012-08-01 | 4,166 | $14.25 | $59.4K | 42,843 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | U Tender | 2012-07-30 | 2012-08-01 | 42,843 | $14.25 | $610.5K | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-05-31 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 2,925 | — | $0 | 19,739 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 1,796 | — | $0 | 21,535 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award deriv | 2012-05-17 | 2012-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-05-17 | 2012-05-21 | 2,500 | — | $0 | 47,009 | SEC↗ |